Weigao Orthopaedic(SH:688161) Xin Lang Cai Jing·2025-08-27 17:19Core Viewpoint - Shandong Weigao Orthopedic Materials Co., Ltd. announced plans to use part of its idle funds for cash management, aiming to enhance fund efficiency and returns while ensuring normal operations and fund safety [1][2]. Cash Management Overview - Investment Purpose: To improve fund efficiency and returns while safeguarding normal operations and fund safety, ultimately benefiting shareholders [2]. - Investment Products: The company plans to invest in high-security, liquid financial products with capital protection agreements, such as principal-protected wealth management products, structured deposits, and fixed-term deposits [2]. - Decision Validity: The resolution is valid for 12 months from the date of board approval, with a maximum investment of RMB 2.3 billion [2]. - Implementation: The board authorizes the chairman and management to make investment decisions within the approved limits and timeframe [2]. - Information Disclosure: The company will comply with legal requirements for timely information disclosure [2]. Risk Management and Control - The company has implemented several risk control measures, including selecting reputable financial institutions, real-time monitoring of product performance, and prohibiting personal account operations [3]. - Internal audits will evaluate investment risks and returns, with oversight from independent directors and the supervisory board [3]. Impact on the Company - The cash management initiative will not affect the company's main business operations or shareholder interests, and is expected to enhance fund efficiency and returns [4]. - Both the board and supervisory board have expressed clear agreement on the cash management plan, deeming it compliant with relevant requirements [4].